Last reviewed · How we verify
HGF Plasmid — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
HGF Plasmid (HGF Plasmid) — AnGes USA, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HGF Plasmid TARGET | HGF Plasmid | AnGes USA, Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HGF Plasmid CI watch — RSS
- HGF Plasmid CI watch — Atom
- HGF Plasmid CI watch — JSON
- HGF Plasmid alone — RSS
Cite this brief
Drug Landscape (2026). HGF Plasmid — Competitive Intelligence Brief. https://druglandscape.com/ci/hgf-plasmid. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab